Back to search

Article

Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer

2020-03-26

Abstract excerpt

<h4>BACKGROUND</h4> A significant gap in pancreatic ductal adenocarcinoma (PDAC) patient’s care is the lack of molecular parameters characterizing tumors and allowing a personalized treatment. The goal of this study was to examine whole PDAC transcriptomic profiles to define a signature that would predict aggressiveness and treatment responsiveness better than done until now. <h4>METHODS AND PATIENTS</h4> Tumors...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
018d2725-a2fe-5c3e-b2a6-970bb988d24b
DOI
10.1101/2020.03.25.998138
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancerDOI 10.1101/2020.03.25.998138
Select a neighboring publication to make it the new centre.